BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30770753)

  • 1. Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer-a retrospective observational study.
    Matsuoka H; Morise Z; Tanaka C; Hayashi T; Ikeda Y; Maeda K; Masumori K; Koide Y; Katsuno H; Tanahashi Y; Nakajima S; Hanai T; Kato Y; Sugioka A; Uyama I
    World J Surg Oncol; 2019 Feb; 17(1):33. PubMed ID: 30770753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
    Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
    Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effective.
    Jones NB; McNally ME; Malhotra L; Abdel-Misih S; Martin EW; Bloomston M; Schmidt CR
    Ann Surg Oncol; 2012 Jul; 19(7):2224-9. PubMed ID: 22207046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
    Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
    World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
    Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
    HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases.
    Ahmad A; Chen SL; Bilchik AJ
    Arch Surg; 2007 Jun; 142(6):526-31; discussion 531-2. PubMed ID: 17576888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease?
    Kataoka K; Kanazawa A; Iwamoto S; Kato T; Nakajima A; Arimoto A
    World J Surg; 2014 Apr; 38(4):936-46. PubMed ID: 24166026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer.
    Yamada H; Katoh H; Kondo S; Okushiba S; Morikawa T
    Hepatogastroenterology; 2001; 48(39):828-30. PubMed ID: 11462933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.
    Padman S; Padbury R; Beeke C; Karapetis CS; Bishnoi S; Townsend AR; Maddern G; Price TJ
    Acta Oncol; 2013 Nov; 52(8):1699-706. PubMed ID: 24102180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of "Watch-and-Wait" Management before Repeat Hepatectomy for Colorectal Liver Metastases.
    Kishi Y; Nara S; Esaki M; Shimada K
    Dig Surg; 2019; 36(3):233-240. PubMed ID: 29597209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.
    Battula N; Tsapralis D; Mayer D; Isaac J; Muiesan P; Sutcliffe RP; Bramhall S; Mirza D; Marudanayagam R
    HPB (Oxford); 2014 Feb; 16(2):157-63. PubMed ID: 23530978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
    Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
    Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after repeat hepatic resection for recurrent colorectal metastases.
    Chiappa A; Zbar AP; Biella F; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat hepatectomy for colorectal liver metastases.
    Adam R; Bismuth H; Castaing D; Waechter F; Navarro F; Abascal A; Majno P; Engerran L
    Ann Surg; 1997 Jan; 225(1):51-60; discussion 60-2. PubMed ID: 8998120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver metastases from gastric carcinoma: A Case report and review of the literature.
    Polkowska-Pruszyńska B; Rawicz-Pruszyński K; Ciseł B; Sitarz R; Polkowska G; Krupski W; Polkowski WP
    Curr Probl Cancer; 2017; 41(3):222-230. PubMed ID: 28625333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases.
    Scoggins CR; Campbell ML; Landry CS; Slomiany BA; Woodall CE; McMasters KM; Martin RC
    Ann Surg Oncol; 2009 Jan; 16(1):35-41. PubMed ID: 18987915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
    Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
    J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
    Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
    Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.